Novartis Oncology Universal Co-pay Program
You may be eligible for immediate co-pay savings on your next prescription of TAFINLAR or MEKINIST.
Eligible patients with private insurance may pay $0 per month ($0 per month for a 30-day supply of TAFINLAR and $0 for a 30-day supply of MEKINIST). Co-pay of $0 is only for TAFINLAR and MEKINIST combination therapy
Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*